| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 90,086 | 97,909 | 109,647 | 121,031 | | Cost of Revenue | 39,741 | 40,879 | 40,571 | 40,169 | | | Gross Profit | 50,345 | 57,030 | 69,076 | 80,862 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,864 | 7,676 | 8,762 | 10,437 | | Non Recurring | 241 | 4 | (245) |
-
| | Others | 16,514 | 44,312 | 15,148 | 13,962 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 27,072 | 5,038 | 45,411 | 56,463 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 511 | 38 | (101) | 204 | | Earnings Before Interest And Taxes | 27,237 | 5,076 | 45,310 | 56,667 | | Interest Expense | 5,586 | 4,267 | 2,731 | 2,187 | | Income Before Tax | 21,651 | 809 | 42,579 | 54,480 | | Income Tax Expense | 7,877 | 610 | 15,478 | 19,399 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 13,774 | 199 | 27,101 | 35,081 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 13,774 | 199 | 27,101 | 35,081 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $13,774 | $199 | $27,101 | $35,081 |
|
0.03% Nasdaq 
Income Statement
